Results 181 to 190 of about 4,149,276 (205)
Some of the next articles are maybe not open access.
The American Journal of Gastroenterology, 2005
Coeliac disease (CD) is found in 5-10% of patients with chronically abnormal liver tests and no obvious cause of liver disease. In this population the efficacy of screening for CD by anti-tissue transglutaminase (anti-tTG) may be impaired by the high rate of positive anti-tTG found in chronic liver disease.To evaluate the prevalence of coeliac disease ...
Oreste, Lo Iacono +9 more
openaire +2 more sources
Coeliac disease (CD) is found in 5-10% of patients with chronically abnormal liver tests and no obvious cause of liver disease. In this population the efficacy of screening for CD by anti-tissue transglutaminase (anti-tTG) may be impaired by the high rate of positive anti-tTG found in chronic liver disease.To evaluate the prevalence of coeliac disease ...
Oreste, Lo Iacono +9 more
openaire +2 more sources
[Relevance of anti-tissue transglutaminase antibodies in coeliac disease diagnosis].
Annales de biologie clinique, 2003Coeliac disease is precipitated upon exposure to the dietary wheat gluten. Definitive diagnosis relies on intestinal biopsy and regression of clinical and histological disorders with adherence to a gluten-free diet. Coeliac disease is usually associated with a malabsorption syndrome.
S, Lepers +8 more
openaire +1 more source
2013
In celiac disease (CD), gluten, the disease-inducing toxic component in wheat, induces the secretion of IgA-class autoantibodies which target tissue transglutaminase (tTG). These autoantibodies are produced in the small-intestinal mucosa, and, during gluten consumption, they can also be detected in patients' serum but disappear slowly from the ...
Caputo I +6 more
openaire +2 more sources
In celiac disease (CD), gluten, the disease-inducing toxic component in wheat, induces the secretion of IgA-class autoantibodies which target tissue transglutaminase (tTG). These autoantibodies are produced in the small-intestinal mucosa, and, during gluten consumption, they can also be detected in patients' serum but disappear slowly from the ...
Caputo I +6 more
openaire +2 more sources
Plasma IgG anti-tissue transglutaminase antibodies in the diagnosis of necrotizing enterocolitis
Background: Necrotizing enterocolitis (NEC) is a severe inflammatory gastrointestinal disease that affects premature neonates with high morbidity and mortality. We aimed to evaluate the potential of IgG anti-tissue transglutaminase antibodies (IgG tTG) as biomarkers for NEC and to explore their applicability in the ...Hua Li +9 more
openaire +1 more source
1P Anti-tissue transglutaminase antibodies in IBD patients
Digestive and Liver Disease, 2002M. Di Tola +7 more
openaire +1 more source
Anti-tissue transglutaminase antibodies and infectious diseases in children
Digestive and Liver Disease, 2008S. Pastore +6 more
openaire +1 more source
Antitissue Transglutaminase and Antiendomysial Antibodies
2007E. TONUTTI, N. BIZZARO
openaire +1 more source
INFLUENCE OF AGE ON ANTI‐TISSUE‐TRANSGLUTAMINASE IGA ANTIBODIES
Journal of Pediatric Gastroenterology and Nutrition, 2006A VÉcsei +5 more
openaire +1 more source
Anti-tissue transglutaminase antibodies in spondyloarthropathy: A marker of tissue lesion
Digestive and Liver Disease, 2001A. Picarelli +5 more
openaire +1 more source

